
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Cyclopharm Limited is a medical devices business based in Australia. Cyclopharm shares (CYC) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Cyclopharm has a trailing 12-month revenue of around $16.3 million.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
Since the stock market crash in March caused by coronavirus, Cyclopharm 's share price has had significant positive movement.
Its last market close was $2, which is 46.75% up on its pre-crash value of $1.065 and 185.71% up on the lowest point reached during the March crash when the shares fell as low as $0.7.
If you had bought $1,000 worth of Cyclopharm shares at the start of February 2020, those shares would have been worth $660.72 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,785.72.
52-week range | $0.7 - $3.3 |
---|---|
50-day moving average | $2.0165 |
200-day moving average | $1.5479 |
Target price | $1.15 |
PE ratio | N/A |
Dividend yield | $0.01 (0.45%) |
Earnings per share (TTM) | $-0.035 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$2 on 2020-10-22
1 week (2021-01-07) | -21.88% |
---|---|
1 month (2020-12-17) | -13.79% |
3 months (2020-10-16) | -11.89% |
6 months (2020-07-17) | 36.05% |
1 year (2020-01-17) | 57.48% |
---|---|
2 years (2019-01-17) | 84.33% |
3 years (2018-01-15) | 109.42% |
5 years (2016-01-14) | 288.12% |
Revenue TTM | $16.3 million |
---|---|
Gross profit TTM | $14.1 million |
Return on assets TTM | -13.49% |
Return on equity TTM | -36.06% |
Profit margin | -34.02% |
Book value | 0.214 |
Market capitalisation | $172.6 million |
TTM: trailing 12 months
We're not expecting Cyclopharm to pay a dividend over the next 12 months.
Cyclopharm 's shares were split on a 1:5 basis on 28 May 2012. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cyclopharm shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Cyclopharm shares which in turn could have impacted Cyclopharm 's share price.
Over the last 12 months, Cyclopharm 's shares have ranged in value from as little as $0.7 up to $3.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Cyclopharm 's is 0.1847. This would suggest that Cyclopharm 's shares are less volatile than average (for this exchange).
Cyclopharm Limited engages in the research and development, manufacture, and sale of medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. It offers diagnostic equipment and consumables, which are used by physicians in the detection of pulmonary embolism. The company also provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. It serves nuclear medicine departments in hospitals. The company has research collaboration agreement with McMasters University and others to understand the short-term and long-term effects of COVID-19 on lung ventilation and perfusion injury. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
From the best RC plane for beginners to the top model for aerial photography, these are the six best RC planes in Australia right now.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.